Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Gastroenterology Physician in Clearwater, FL
NPI: 1215026158Primary Practice Location
MORTON PLANT HOSPITAL
300 Pinellas St, Clearwater, FL
Primary Employer
West Central Gastroenterology LLP
gastrofl.com
HQ Phone
Get M.D. Lawrence's Phone Numberphone_androidMobile
Get M.D. Lawrence's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1995 - 2027
GA State Medical License
1991 - 1997
New York Medical College
nymc.edu
Medical School
Until 1990
Emory School of Medicine
med.emory.edu
Residency • Internal Medicine
1990 - 1993
Fellowship • Gastroenterology
1993 - 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 205 | 261 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 163 | 163 |
| 3 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 101 | 105 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 100 | 144 |
| 5 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | 84 |
Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.
Authors: Leonard Medeiros, Roger Warnke
Journal: Am J Pathol
Utility of BCL2, PD1, and CD25 immunohistochemical expression in the diagnosis of T-cell lymphomas.
Authors: Kate Grimm
Authors: Weiss, L M, Movahed, L A, Chen, Y Y, Shin, S S, Stroup, R M, Bui, N, Estess, P, Bindl, J M
Journal: Am J Pathol
Lead Sponsor: Celltrion
Intervention / Treatment: BIOLOGICAL: CT-P13 SC (Infliximab), OTHER: Placebo SC
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Mirikizumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab, DRUG: Ustekinumab
